Learn more about CKB methodology, utility, and design from the original CKB publication.
The CKB is a dynamic digital resource for interpreting complex cancer genomic profiles. Join thousands of clinicians and researchers across the globe, saving time and finding valuable information that connects cancer variants to therapies and clinical trials.
JAX-CKB can help increase clinician confidence in completeness and accuracy of the information related to the patient’s tumor genomic profile.
For translational and clinical researchers, JAX-CKB provides thousands of literature citations, FDA drug labels, and clinical trials relative to a tumor’s genomic mutation or profile, resulting in a clear and up-to-date picture of discoveries and active developments for a variety of biomarkers.